Taken together, these findings suggest that SCAT1, SCAT2, and SCAT8 may act as new oncogenic drivers and prognostic markers in CRC, potentially contributing to carcinogenesis and tumor progression. The gene discussed is SCAT1; the disease is colorectal carcinoma.